Delivery Order SPE2DR25D1110-SPE2DR26F13BS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,071.88 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in 30-tablet units. This contract, awarded on June 4, 2025, with completion targeted for June 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively issued and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $3,382.75 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units, valued at $4,993.44. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was awarded on a competitive basis without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,466.34 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $7,037.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 14, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,947.10 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX and valued at $999,999,999.00 through December 2026). The award...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,899.87 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg TimeSpan, a neurological medication used in military and veteran healthcare systems. This competitive award, issued on September 25, 2025, with completion targeted for September 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $35,530.01 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a direct procurement of pharmaceutical products to support military and federal healthcare operations. The contract was competitively awarded with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a $10.87K delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan tablets (30-count units) under a firm fixed-price contract structure. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,095.12 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order was placed on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F13BSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,543.25 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 21, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates extensive experience delivering specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Mestinon is a medication commonly used to treat myasthenia gravis and other neuromuscular conditions, reflecting the company's role as a critical vendor for specialized pharmaceutical needs within the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 11/20/25 |